Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Hinge Health $503 million IPO
The shares are listed on the New York Stock Exchange
Mirion Technologies $400 million convertible senior notes offering
We advised Mirion Technologies on the offering
Texas Instruments $1.2 billion notes offering
We advised Texas Instruments on its investment-grade debt offering
Medallion Bank preferred stock offering
The preferred stock is listed on the Nasdaq Capital Market
Strategy $2.1 billion perpetual strife preferred stock at-the-market offering
The perpetual strife preferred stock is listed on the Nasdaq Global Select Market
Qualcomm $1.5 billion notes offering
The investment-grade notes are due 2030, 2032 and 2035
Equinix €1.5 billion green bond offering
We advised Equinix on the investment-grade notes offering
Uber Technologies $1.15 billion exchangeable notes offering
The 0% exchangeable senior notes are due 2028
Atara Biotherapeutics registered direct offering
The stock is listed on Nasdaq
Shift4 Payments $550 million and €680 million notes offerings
The high-yield notes are part of the financing for Shift4 Payments’ acquisition of Global Blue Group Holdings